-
1دورية أكاديمية
المؤلفون: Staehler, M, Motzer, RJ, George, DJ, Pandha, HS, Donskov, F, Escudier, B, Pantuck, AJ, Patel, A, DeAnnuntis, L, Bhattacharyya, H, Ramaswamy, K, Zanotti, G, Lin, X, Lechuga, M, Serfass, L, Paty, J, Ravaud, A
المصدر: Annals of Oncology. 29(10)
مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Kidney Disease, Rare Diseases, Patient Safety, Clinical Research, Clinical Trials and Supportive Activities, Cancer, Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, Antineoplastic Agents, Carcinoma, Renal Cell, Chemotherapy, Adjuvant, Disease Management, Double-Blind Method, Follow-Up Studies, Humans, International Agencies, Kidney Neoplasms, Neoplasm Recurrence, Local, Patient Reported Outcome Measures, Prognosis, Prospective Studies, Quality of Life, Sunitinib, Survival Rate, renal cell carcinoma, adjuvant sunitinib, cancer, patient-reported outcomes, Oncology & Carcinogenesis, Clinical sciences, Oncology and carcinogenesis
وصف الملف: application/pdf
URL الوصول: https://escholarship.org/uc/item/6jk6f07h
-
2دورية أكاديمية
المؤلفون: Faiena I, Cummings AL, Crosetti AM, Pantuck AJ, Chamie K, Drakaki A
المصدر: Drug Design, Development and Therapy, Vol Volume 12, Pp 209-215 (2018)
مصطلحات موضوعية: Durvalumab, checkpoint inhibitors, metastatic urothelial carcinoma, Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
-
3دورية أكاديمية
المؤلفون: Pantuck, AJ, Zismon, A, Tso, C-L, Belldegrun, AS
المصدر: Prostate Cancer and Prostatic Diseases. 3(4):280-282
-
4
المؤلفون: Ravaud, A, Motzer, Rj, Pandha, Hs, George, Dj, Pantuck, Aj, Patel, A, Chang, Yh, Escudier, B, Donskov, F, Magheli, A, Carteni, G, Laguerre, B, Tomczak, P, Breza, J, Gerletti, P, Lechuga, M1, Lin, X, Martini, Jf, Ramaswamy, K, Casey, M, Staehler, M, Patard, Jj, Gruenwald, V, Link, K, Doehn, C, Heinzer, H, Grimm, M-O, Wirth, M, Stoeckle, M, Heidenreich, A, Garcia del Muro Solans, X, Mellado, Bo, Castellano, Dg, Frydenberg, M, Schobinger, Sr, Dimopoulos, Ma, Rothermundt, C, Climent Duran MA, Melotti, B, Procopio, G, Boccardo, F, Sella, A, Stewart, S, Adenis, A, Jones, Rj, Chevreau, C, Prausova, J, Vyzula, R, Oudard, S, Jacqmin, D, Gravis, G, Varela, R, Herrmann, E, Lim, Hy, Lee, J-L, Kim, Yh, Kim, Jh, Y-C, Ou, Papakotoulas, P, Iacobelli, S, Chowdhury, S, Passalacqua, R, Tomasek, J, Anton Aparicio LM, Linassier, C, Hauser, S, Bergmann, L, Hawkins, Re, Szczylik, C, Zdrojowy, R, Sosnowski, M, Koralewski, P, Wiechnio, Pj, Schraml, J, Mardiak, J, Laurinc, P, Kliment, J, Rosenbaum, E, Lundstam, S, Flodgren, P, Ljungberg, B, Stenzl, A, Schnoeller, Tj, Mcdermott, Sr, Breathnach, Os, Mccaffrey, Ja, Donnellan, P, The, G-C, Rolland, F, Brekkan, E, Nilsson, C, Kim, Wy, Bishoff, J, Chung, J, Shore, Nd, Master, V, Tang Chen DY, Ye, D, Huang, Y, Jin, J, Song, B, Zhou, F, Galceran, Jc, Yao, X, Zhang, X.
المصدر: Ravaud, A, Motzer, R J, Pandha, H S, George, D J, Pantuck, A J, Patel, A, Chang, Y-H, Escudier, B, Donskov, F, Magheli, A, Carteni, G, Laguerre, B, Tomczak, P, Gerletti, P, Lechuga, M, Lin, X, Martini, J-F, Ramaswamy, K, Casey, M, Staehler, M, Patard, J-J & S-TRAC Investigators 2016, ' Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy ', The New England Journal of Medicine, vol. 375, no. 23, pp. 2246-2254 . https://doi.org/10.1056/NEJMoa1611406
مصطلحات موضوعية: Male, Indoles, medicine.medical_treatment, Clinical Trial, Phase III, 030232 urology & nephrology, Nephrectomy, 0302 clinical medicine, Renal cell carcinoma, Clinical endpoint, 80 and over, Adjuvant, Aged, 80 and over, Adolescent, Adult, Aged, Antineoplastic Agents, Carcinoma, Renal Cell, Chemotherapy, Adjuvant, Double-Blind Method, Drug Administration Schedule, Female, Humans, Kidney Neoplasms, Middle Aged, Pyrroles, Survival Analysis, Young Adult, Medicine (all), Sunitinib, General Medicine, Multicenter Study, 030220 oncology & carcinogenesis, Randomized Controlled Trial, medicine.drug, medicine.medical_specialty, Urology, Placebo, 03 medical and health sciences, Journal Article, Carcinoma, medicine, Chemotherapy, Survival analysis, business.industry, Renal Cell, medicine.disease, Surgery, Clinical trial, business
وصف الملف: text
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::044148e0163ba78bfbd9d2be3de578c8
https://surrey.eprints-hosting.org/812586/ -
5
المؤلفون: Bigot, P, Bernhard, Jc, Crepel, M, Bensalah, K, Azzouzi, Ar, de la Taille, A, Salomon, L, Tostain, J, Ficarra, Vincenzo, Pantuck, Aj, Belldegrun, As, Méjean, A, Ferrière, Jm, Pfister, C, Albouy, B, Colombel, M, Zini, L, Villers, A, Montorsi, F, Shariat, S, Rioux Leclercq, N, Patard, Jj
المصدر: Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 20(5)
مصطلحات موضوعية: Adult, Aged, 80 and over, Male, renal cell carcinoma, partial nephrectomy, radical nephrectomy, Middle Aged, Nephrectomy, Kidney Neoplasms, Humans, Female, Carcinoma, Renal Cell, Aged, Neoplasm Staging, Retrospective Studies
-
6
المؤلفون: Karakiewicz, Pi, Suardi, N, Capitanio, U, Isbarn, H, Jeldres, C, Perrotte, P, Sun, M, Ficarra, Vincenzo, Zigeuner, R, Tostain, J, Mejean, A, Cindolo, L, Pantuck, Aj, Belldegrun, As, Zini, L, DE LA TAILLE, A, Chautard, D, Descotes, Jl, Shariat, Sf, Valeri, A, Mulders, Pf, Lang, H, Lechevallier, E, Patard, Jj
مصطلحات موضوعية: renal cell carcinoma, prognostic factors
URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______3657::ccfad56d393e83765b04ca7efd56466a
http://hdl.handle.net/11577/2377668 -
7دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
8دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
9دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
10دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.